IVBXF (IVBXF) Stock Price & Analysis
IVBXF (IVBXF) rose 0.57% to USD 13.19 as of September 9, 2026 at 22:08 UTC, according to Nexqual real-time market data.
IVBXF last closed at USD 13.19; the session ranged USD 13–13 on volume of 4,000 shares. Market capitalization is —, with a 52-week range of USD 9.1–15.01 (PNK). Source: Nexqual, September 9, 2026 at 22:08 UTC.
Key Statistics (as of September 9, 2026 at 22:08 UTC)
| Price | USD 13.19 |
|---|---|
| Change | ▲ 0.57% (up) |
| Previous Close | USD 13.19 |
| Open | USD 13.19 |
| Day Range | USD 13 – 13 |
| 52-Week Range | USD 9.1 – 15.01 |
| Volume | 4,000 shares |
| Market Cap | — |
| Exchange | PNK |
Technical Analysis (IVBXF)
Nexqual's technical model rates IVBXF "STRONG BUY" based on 5 bullish and 0 bearish signals across 126 daily candles, as of September 9, 2026 at 22:08 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 50.89 (neutral) |
| vs SMA50 | Above (USD 12.11) |
| MACD | 0.39 (positive) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| WXIBF | Wuxi Biologics (Cayman) Inc | USD 6.23 | ▲ 0% |
| WXXWY | Wuxi Biologics (Cayman) Inc | USD 12.4 | ▼ 1.2% |
| UCBJY | UCB S.A. | USD 118.75 | ▼ 2.96% |
| GNMSF | Genmab A/S | USD 329.25 | ▲ 0% |
| GNNSF | Genscript Biotech Corp | USD 4 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 9, 2026 at 22:08 UTC. This page is informational and not investment advice.